Dr. Robert A. Mangione Talks About NFCA/FDA Study and Celiac Disease on Health Talk

January 30, 2012

Dr. Robert Mangione, Dean of the College of Pharmacy and Allied Health Professions at St. John’s University, was a guest on Health Talk, a nationally-syndicated radio program hosted by Dr. Ronald Hoffman, on Wednesday afternoon.   The topic of the Daily Feature was the dangers of gluten in medications for patients with celiac disease.

The 35-minute segment initially aired on WOR Radio (710 AM) at 12 a.m. January 26, but can be heard via podcast here

Dr. Mangione, along with Dr. S. William Zito, Professor of Pharmaceutical Sciences and Dr. Somnath Pal, Professor of Pharmacy Administration, have partnered with the National Foundation for Celiac Awareness (NFCA) to survey individuals with gluten intolerance to determine if they believe that they have experienced an adverse drug event due to the presence of gluten in a medication. The survey results will also be used to identify representative over-the-counter and prescription drugs that were reported to cause adverse effects which they will analyze to determine their gluten content. 

This project, entitled, “Gluten in Medication: Qualifying the extent of exposure to people with celiac disease and identifying a hidden and preventable cause of an adverse drug event” is funded by a $50,000 grant awarded to NFCA by the Food and Drug Administration (FDA).  Dr. Mangione, who is a NFCA Scientific/Medical Advisory Board Member, Dr. Zito, and Dr. Pal were asked to work with NFCA to conduct the research in just a few short weeks. Over two-thousand responses to the initial survey distributed to the celiac disease patient population have been received already and more responses are anticipated.
  
Click here to read more about the NFCA study.